世界の急性＆慢性肝不全市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Acute On Chronic Liver Failure Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3759
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、急性＆慢性肝不全の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（手術、医薬品、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・急性＆慢性肝不全の市場動向
・企業の競争状況、市場シェア
・急性＆慢性肝不全の種類別市場規模と予測2016-2027（手術、医薬品、その他）
・急性＆慢性肝不全の用途別市場規模と予測2016-2027（病院、診療所、その他）
・急性＆慢性肝不全の北米市場規模2016-2027（アメリカ、カナダ）
・急性＆慢性肝不全の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・急性＆慢性肝不全のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・急性＆慢性肝不全の中南米市場規模2016-2027（メキシコ、ブラジル）
・急性＆慢性肝不全の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Grifols Therapeutics、Promethera Biosciences、RHEACELL、Versantis AG、Martin pharmaceuticals）
・結論

Acute-on-chronic liver failure is a syndrome that affects patients with chronic liver disease; is characterized by intense systemic inflammation, organ failure, and a poor prognosis; and frequently develops in close association with precipitating events. There is no specific treatment for patients with ACLF, and management is based on organ support, management of complications associated with specific etiologies, and liver transplantation.

Market Analysis and Insights: Global Acute On Chronic Liver Failure Market
The global Acute On Chronic Liver Failure market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acute On Chronic Liver Failure market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Acute On Chronic Liver Failure market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Acute On Chronic Liver Failure market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Acute On Chronic Liver Failure market.

Global Acute On Chronic Liver Failure Scope and Market Size
Acute On Chronic Liver Failure market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Acute On Chronic Liver Failure market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Surgery
Medication
Others

Segment by Application
Hospital
Clinic
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Grifols Therapeutics
Promethera Biosciences
RHEACELL
Versantis AG
Martin pharmaceuticals

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute On Chronic Liver Failure Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Surgery
1.2.3 Medication
1.2.4 Others
1.3 Market by Application
1.3.1 Global Acute On Chronic Liver Failure Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Acute On Chronic Liver Failure Market Perspective (2016-2027)
2.2 Acute On Chronic Liver Failure Growth Trends by Regions
2.2.1 Acute On Chronic Liver Failure Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Acute On Chronic Liver Failure Historic Market Share by Regions (2016-2021)
2.2.3 Acute On Chronic Liver Failure Forecasted Market Size by Regions (2022-2027)
2.3 Acute On Chronic Liver Failure Industry Dynamic
2.3.1 Acute On Chronic Liver Failure Market Trends
2.3.2 Acute On Chronic Liver Failure Market Drivers
2.3.3 Acute On Chronic Liver Failure Market Challenges
2.3.4 Acute On Chronic Liver Failure Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Acute On Chronic Liver Failure Players by Revenue
3.1.1 Global Top Acute On Chronic Liver Failure Players by Revenue (2016-2021)
3.1.2 Global Acute On Chronic Liver Failure Revenue Market Share by Players (2016-2021)
3.2 Global Acute On Chronic Liver Failure Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Acute On Chronic Liver Failure Revenue
3.4 Global Acute On Chronic Liver Failure Market Concentration Ratio
3.4.1 Global Acute On Chronic Liver Failure Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute On Chronic Liver Failure Revenue in 2020
3.5 Acute On Chronic Liver Failure Key Players Head office and Area Served
3.6 Key Players Acute On Chronic Liver Failure Product Solution and Service
3.7 Date of Enter into Acute On Chronic Liver Failure Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Acute On Chronic Liver Failure Breakdown Data by Type
4.1 Global Acute On Chronic Liver Failure Historic Market Size by Type (2016-2021)
4.2 Global Acute On Chronic Liver Failure Forecasted Market Size by Type (2022-2027)

5 Acute On Chronic Liver Failure Breakdown Data by Application
5.1 Global Acute On Chronic Liver Failure Historic Market Size by Application (2016-2021)
5.2 Global Acute On Chronic Liver Failure Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Acute On Chronic Liver Failure Market Size (2016-2027)
6.2 North America Acute On Chronic Liver Failure Market Size by Type
6.2.1 North America Acute On Chronic Liver Failure Market Size by Type (2016-2021)
6.2.2 North America Acute On Chronic Liver Failure Market Size by Type (2022-2027)
6.2.3 North America Acute On Chronic Liver Failure Market Size by Type (2016-2027)
6.3 North America Acute On Chronic Liver Failure Market Size by Application
6.3.1 North America Acute On Chronic Liver Failure Market Size by Application (2016-2021)
6.3.2 North America Acute On Chronic Liver Failure Market Size by Application (2022-2027)
6.3.3 North America Acute On Chronic Liver Failure Market Size by Application (2016-2027)
6.4 North America Acute On Chronic Liver Failure Market Size by Country
6.4.1 North America Acute On Chronic Liver Failure Market Size by Country (2016-2021)
6.4.2 North America Acute On Chronic Liver Failure Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Acute On Chronic Liver Failure Market Size (2016-2027)
7.2 Europe Acute On Chronic Liver Failure Market Size by Type
7.2.1 Europe Acute On Chronic Liver Failure Market Size by Type (2016-2021)
7.2.2 Europe Acute On Chronic Liver Failure Market Size by Type (2022-2027)
7.2.3 Europe Acute On Chronic Liver Failure Market Size by Type (2016-2027)
7.3 Europe Acute On Chronic Liver Failure Market Size by Application
7.3.1 Europe Acute On Chronic Liver Failure Market Size by Application (2016-2021)
7.3.2 Europe Acute On Chronic Liver Failure Market Size by Application (2022-2027)
7.3.3 Europe Acute On Chronic Liver Failure Market Size by Application (2016-2027)
7.4 Europe Acute On Chronic Liver Failure Market Size by Country
7.4.1 Europe Acute On Chronic Liver Failure Market Size by Country (2016-2021)
7.4.2 Europe Acute On Chronic Liver Failure Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Acute On Chronic Liver Failure Market Size (2016-2027)
8.2 Asia-Pacific Acute On Chronic Liver Failure Market Size by Type
8.2.1 Asia-Pacific Acute On Chronic Liver Failure Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Acute On Chronic Liver Failure Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Acute On Chronic Liver Failure Market Size by Type (2016-2027)
8.3 Asia-Pacific Acute On Chronic Liver Failure Market Size by Application
8.3.1 Asia-Pacific Acute On Chronic Liver Failure Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Acute On Chronic Liver Failure Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Acute On Chronic Liver Failure Market Size by Application (2016-2027)
8.4 Asia-Pacific Acute On Chronic Liver Failure Market Size by Region
8.4.1 Asia-Pacific Acute On Chronic Liver Failure Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Acute On Chronic Liver Failure Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Acute On Chronic Liver Failure Market Size (2016-2027)
9.2 Latin America Acute On Chronic Liver Failure Market Size by Type
9.2.1 Latin America Acute On Chronic Liver Failure Market Size by Type (2016-2021)
9.2.2 Latin America Acute On Chronic Liver Failure Market Size by Type (2022-2027)
9.2.3 Latin America Acute On Chronic Liver Failure Market Size by Type (2016-2027)
9.3 Latin America Acute On Chronic Liver Failure Market Size by Application
9.3.1 Latin America Acute On Chronic Liver Failure Market Size by Application (2016-2021)
9.3.2 Latin America Acute On Chronic Liver Failure Market Size by Application (2022-2027)
9.3.3 Latin America Acute On Chronic Liver Failure Market Size by Application (2016-2027)
9.4 Latin America Acute On Chronic Liver Failure Market Size by Country
9.4.1 Latin America Acute On Chronic Liver Failure Market Size by Country (2016-2021)
9.4.2 Latin America Acute On Chronic Liver Failure Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Acute On Chronic Liver Failure Market Size (2016-2027)
10.2 Middle East & Africa Acute On Chronic Liver Failure Market Size by Type
10.2.1 Middle East & Africa Acute On Chronic Liver Failure Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Acute On Chronic Liver Failure Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Acute On Chronic Liver Failure Market Size by Type (2016-2027)
10.3 Middle East & Africa Acute On Chronic Liver Failure Market Size by Application
10.3.1 Middle East & Africa Acute On Chronic Liver Failure Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Acute On Chronic Liver Failure Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Acute On Chronic Liver Failure Market Size by Application (2016-2027)
10.4 Middle East & Africa Acute On Chronic Liver Failure Market Size by Country
10.4.1 Middle East & Africa Acute On Chronic Liver Failure Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Acute On Chronic Liver Failure Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Grifols Therapeutics
11.1.1 Grifols Therapeutics Company Details
11.1.2 Grifols Therapeutics Business Overview
11.1.3 Grifols Therapeutics Acute On Chronic Liver Failure Introduction
11.1.4 Grifols Therapeutics Revenue in Acute On Chronic Liver Failure Business (2016-2021)
11.1.5 Grifols Therapeutics Recent Development
11.2 Promethera Biosciences
11.2.1 Promethera Biosciences Company Details
11.2.2 Promethera Biosciences Business Overview
11.2.3 Promethera Biosciences Acute On Chronic Liver Failure Introduction
11.2.4 Promethera Biosciences Revenue in Acute On Chronic Liver Failure Business (2016-2021)
11.2.5 Promethera Biosciences Recent Development
11.3 RHEACELL
11.3.1 RHEACELL Company Details
11.3.2 RHEACELL Business Overview
11.3.3 RHEACELL Acute On Chronic Liver Failure Introduction
11.3.4 RHEACELL Revenue in Acute On Chronic Liver Failure Business (2016-2021)
11.3.5 RHEACELL Recent Development
11.4 Versantis AG
11.4.1 Versantis AG Company Details
11.4.2 Versantis AG Business Overview
11.4.3 Versantis AG Acute On Chronic Liver Failure Introduction
11.4.4 Versantis AG Revenue in Acute On Chronic Liver Failure Business (2016-2021)
11.4.5 Versantis AG Recent Development
11.5 Martin pharmaceuticals
11.5.1 Martin pharmaceuticals Company Details
11.5.2 Martin pharmaceuticals Business Overview
11.5.3 Martin pharmaceuticals Acute On Chronic Liver Failure Introduction
11.5.4 Martin pharmaceuticals Revenue in Acute On Chronic Liver Failure Business (2016-2021)
11.5.5 Martin pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Acute On Chronic Liver Failure Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Surgery
Table 3. Key Players of Medication
Table 4. Key Players of Others
Table 5. Global Acute On Chronic Liver Failure Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Acute On Chronic Liver Failure Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Acute On Chronic Liver Failure Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Acute On Chronic Liver Failure Market Share by Regions (2016-2021)
Table 9. Global Acute On Chronic Liver Failure Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Acute On Chronic Liver Failure Market Share by Regions (2022-2027)
Table 11. Acute On Chronic Liver Failure Market Trends
Table 12. Acute On Chronic Liver Failure Market Drivers
Table 13. Acute On Chronic Liver Failure Market Challenges
Table 14. Acute On Chronic Liver Failure Market Restraints
Table 15. Global Acute On Chronic Liver Failure Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Acute On Chronic Liver Failure Market Share by Players (2016-2021)
Table 17. Global Top Acute On Chronic Liver Failure Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute On Chronic Liver Failure as of 2020)
Table 18. Ranking of Global Top Acute On Chronic Liver Failure Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Acute On Chronic Liver Failure Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Acute On Chronic Liver Failure Product Solution and Service
Table 22. Date of Enter into Acute On Chronic Liver Failure Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Acute On Chronic Liver Failure Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Acute On Chronic Liver Failure Revenue Market Share by Type (2016-2021)
Table 26. Global Acute On Chronic Liver Failure Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Acute On Chronic Liver Failure Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Acute On Chronic Liver Failure Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Acute On Chronic Liver Failure Revenue Market Share by Application (2016-2021)
Table 30. Global Acute On Chronic Liver Failure Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Acute On Chronic Liver Failure Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Acute On Chronic Liver Failure Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Acute On Chronic Liver Failure Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Acute On Chronic Liver Failure Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Acute On Chronic Liver Failure Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Acute On Chronic Liver Failure Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Acute On Chronic Liver Failure Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Acute On Chronic Liver Failure Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Acute On Chronic Liver Failure Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Acute On Chronic Liver Failure Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Acute On Chronic Liver Failure Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Acute On Chronic Liver Failure Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Acute On Chronic Liver Failure Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Acute On Chronic Liver Failure Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Acute On Chronic Liver Failure Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Acute On Chronic Liver Failure Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Acute On Chronic Liver Failure Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Acute On Chronic Liver Failure Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Acute On Chronic Liver Failure Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Acute On Chronic Liver Failure Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Acute On Chronic Liver Failure Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Acute On Chronic Liver Failure Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Acute On Chronic Liver Failure Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Acute On Chronic Liver Failure Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Acute On Chronic Liver Failure Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Acute On Chronic Liver Failure Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Acute On Chronic Liver Failure Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Acute On Chronic Liver Failure Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Acute On Chronic Liver Failure Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Acute On Chronic Liver Failure Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Acute On Chronic Liver Failure Market Size by Country (2022-2027) & (US$ Million)
Table 62. Grifols Therapeutics Company Details
Table 63. Grifols Therapeutics Business Overview
Table 64. Grifols Therapeutics Acute On Chronic Liver Failure Product
Table 65. Grifols Therapeutics Revenue in Acute On Chronic Liver Failure Business (2016-2021) & (US$ Million)
Table 66. Grifols Therapeutics Recent Development
Table 67. Promethera Biosciences Company Details
Table 68. Promethera Biosciences Business Overview
Table 69. Promethera Biosciences Acute On Chronic Liver Failure Product
Table 70. Promethera Biosciences Revenue in Acute On Chronic Liver Failure Business (2016-2021) & (US$ Million)
Table 71. Promethera Biosciences Recent Development
Table 72. RHEACELL Company Details
Table 73. RHEACELL Business Overview
Table 74. RHEACELL Acute On Chronic Liver Failure Product
Table 75. RHEACELL Revenue in Acute On Chronic Liver Failure Business (2016-2021) & (US$ Million)
Table 76. RHEACELL Recent Development
Table 77. Versantis AG Company Details
Table 78. Versantis AG Business Overview
Table 79. Versantis AG Acute On Chronic Liver Failure Product
Table 80. Versantis AG Revenue in Acute On Chronic Liver Failure Business (2016-2021) & (US$ Million)
Table 81. Versantis AG Recent Development
Table 82. Martin pharmaceuticals Company Details
Table 83. Martin pharmaceuticals Business Overview
Table 84. Martin pharmaceuticals Acute On Chronic Liver Failure Product
Table 85. Martin pharmaceuticals Revenue in Acute On Chronic Liver Failure Business (2016-2021) & (US$ Million)
Table 86. Martin pharmaceuticals Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute On Chronic Liver Failure Market Share by Type: 2020 VS 2027
Figure 2. Surgery Features
Figure 3. Medication Features
Figure 4. Others Features
Figure 5. Global Acute On Chronic Liver Failure Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Others Case Studies
Figure 9. Acute On Chronic Liver Failure Report Years Considered
Figure 10. Global Acute On Chronic Liver Failure Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Acute On Chronic Liver Failure Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Acute On Chronic Liver Failure Market Share by Regions: 2020 VS 2027
Figure 13. Global Acute On Chronic Liver Failure Market Share by Regions (2022-2027)
Figure 14. Global Acute On Chronic Liver Failure Market Share by Players in 2020
Figure 15. Global Top Acute On Chronic Liver Failure Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute On Chronic Liver Failure as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Acute On Chronic Liver Failure Revenue in 2020
Figure 17. Global Acute On Chronic Liver Failure Revenue Market Share by Type (2016-2021)
Figure 18. Global Acute On Chronic Liver Failure Revenue Market Share by Type (2022-2027)
Figure 19. North America Acute On Chronic Liver Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Acute On Chronic Liver Failure Market Share by Type (2016-2027)
Figure 21. North America Acute On Chronic Liver Failure Market Share by Application (2016-2027)
Figure 22. North America Acute On Chronic Liver Failure Market Share by Country (2016-2027)
Figure 23. United States Acute On Chronic Liver Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Acute On Chronic Liver Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Acute On Chronic Liver Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Acute On Chronic Liver Failure Market Share by Type (2016-2027)
Figure 27. Europe Acute On Chronic Liver Failure Market Share by Application (2016-2027)
Figure 28. Europe Acute On Chronic Liver Failure Market Share by Country (2016-2027)
Figure 29. Germany Acute On Chronic Liver Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Acute On Chronic Liver Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Acute On Chronic Liver Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Acute On Chronic Liver Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Acute On Chronic Liver Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Acute On Chronic Liver Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Acute On Chronic Liver Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Acute On Chronic Liver Failure Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Acute On Chronic Liver Failure Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Acute On Chronic Liver Failure Market Share by Region (2016-2027)
Figure 39. China Acute On Chronic Liver Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Acute On Chronic Liver Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Acute On Chronic Liver Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Acute On Chronic Liver Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Acute On Chronic Liver Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Acute On Chronic Liver Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Acute On Chronic Liver Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Acute On Chronic Liver Failure Market Share by Type (2016-2027)
Figure 47. Latin America Acute On Chronic Liver Failure Market Share by Application (2016-2027)
Figure 48. Latin America Acute On Chronic Liver Failure Market Share by Country (2016-2027)
Figure 49. Mexico Acute On Chronic Liver Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Acute On Chronic Liver Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Acute On Chronic Liver Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Acute On Chronic Liver Failure Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Acute On Chronic Liver Failure Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Acute On Chronic Liver Failure Market Share by Country (2016-2027)
Figure 55. Turkey Acute On Chronic Liver Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Acute On Chronic Liver Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Acute On Chronic Liver Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Grifols Therapeutics Revenue Growth Rate in Acute On Chronic Liver Failure Business (2016-2021)
Figure 59. Promethera Biosciences Revenue Growth Rate in Acute On Chronic Liver Failure Business (2016-2021)
Figure 60. RHEACELL Revenue Growth Rate in Acute On Chronic Liver Failure Business (2016-2021)
Figure 61. Versantis AG Revenue Growth Rate in Acute On Chronic Liver Failure Business (2016-2021)
Figure 62. Martin pharmaceuticals Revenue Growth Rate in Acute On Chronic Liver Failure Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

以下、関連資料のご紹介

世界の慢性肝疾患治療薬市場規模・現状・予測（2021年-2027年）

Global Chronic Liver Diseases Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4010 2021年6月 116Pages
QYResearch社発行の本調査レポートでは、慢性肝疾患治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法薬、標的療法、ワクチン、抗ウイルス薬、免疫グロブリン、コルチコステロイド、その他）、用途別市場規模（病院薬局、小売薬局、オンライ...

世界の心不全治療市場規模・現状・予測（2021年-2027年）

Global Heart Failure Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4291 2021年6月 118Pages
QYResearch社発行の本調査レポートでは、心不全治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、手術治療）、用途別市場規模（急性心不全、慢性心不全）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界の心不全検査市場規模・現状・予測（2021年-2027年）

Global Heart Failure Testing Market Size, Status and Forecast 2021-2027
QFJ1-4290 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、心不全検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（心電図検査、血液検査、その他）、用途別市場規模（病院、診断研究所、循環器内科センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界の急性肝性ポルフィリン症用医薬品市場規模・現状・予測（2021年-2027年）

Global Acute Hepatic Porphyria Drug Market Size, Status and Forecast 2021-2027
QFJ1-5564 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、急性肝性ポルフィリン症用医薬品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（350 Mg、313 Mg）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模（北米、アメ...

世界の慢性難治性咳（CRC）治療市場規模・現状・予測（2021年-2027年）

Global Chronic Refractory Cough (CRC) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5661 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、慢性難治性咳（CRC）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（言語療法、理学療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界の慢性片頭痛治療市場規模・現状・予測（2021年-2027年）

Global Chronic Migraine Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4013 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、慢性片頭痛治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、代替治療）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、...

世界の肝がん分子診断市場規模・現状・予測（2021年-2027年）

Global Liver Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4434 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、肝がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、ア...

世界の高血圧＆心不全治療薬市場規模・現状・予測（2021年-2027年）

Global Hypertension and Heart Failure Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4339 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、高血圧＆心不全治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（利尿薬、ベータ遮断薬、エース阻害薬、アルファ遮断薬、その他）、用途別市場規模（男性用、女性用）、主要地域別市場規模（北米、アメリカ、...

世界の慢性歯肉口内炎治療市場規模・現状・予測（2021年-2027年）

Global Chronic Gingivostomatitis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5660 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、慢性歯肉口内炎治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（非ステロイド性抗炎症薬、抗ウイルス薬、抗菌薬、その他）、用途別市場規模（病院＆診療所、大学＆研究機関、その他）、主要地域別市場規模（北...

世界の慢性外傷性脳症（CTE）市場規模・現状・予測（2021年-2027年）

Global Chronic Traumatic Encephalopathy (CTE) Market Size, Status and Forecast 2021-2027
QFJ1-4017 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、慢性外傷性脳症（CTE）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アメリカンフットボール、ホッケー、サッカー（イギリスサッカー）、ラクロス、ラグビー）、用途別市場規模（スポーツ選手、退役軍人、そ...

世界の慢性肝疾患治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Chronic Liver Diseases Therapeutics Market The global Chronic Liver Diseases Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and hig…
肝不全治療薬のグローバル市場調査 2019年 The global Liver Failure Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Liver Failure Therapeutics volume and value at global level, regional level and company level. From a global per…
世界の心不全治療市場規模・現状・予測（2021年-2027年） The main treatment for heart failure is etiological treatment.Because heart failure is the ultimate state of the heart, the causes of heart failure are different.Some people may have hyperthyroidism induced heart failure, and the treatment plan is to actively correct hyperthyroidism.Some people beca…
急性心不全(AHF)治療薬のグローバル市場調査 2019年 The global Acute Heart Failure (AHF) Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Acute Heart Failure (AHF) Therapeutics volume and value at global level, regional level and company …
世界の心不全検査市場規模・現状・予測（2021年-2027年） Heart failure is due to the contraction of the heart function and (or) diastolic function obstacle, blood vein change can not be fully out of the heart, lead to venous blood pooling system, arterial blood perfusion system is insufficient, causing cardiovascular disorders, the disorder syndrome focus…